Are generic compounded semaglutide medications going away (US)?

Just read this article, where its reported that HIMS and HERS are likely exiting the compounded GLP-1 market:

https://www.cnbc.com/2025/02/24/hims-hers-health-hims-q4-earnings-2024.html

It says:

The shares tumbled 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved...

Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days.

Hims & Hers said on the earnings call that as a result, compounded semaglutide will likely not be offered on the platform after the first quarter.

“We will have to start notifying customers in the coming month or two that they will need to start looking for alternative options on the commercial dosing,” Hims & Hers CEO Andrew Dudum said on the call. “I would suspect, just being very direct, that a lot of those patients will try to go into the open market and try to secure a branded option in some form factor.”

Sounds like I missed the boat on accessing these medications in an affordable manner or am I mistaken? Doesn't seem like there's a point to starting a GLP-1 medication now if it won't be accessible 60-90 days from now, and doesn't seem likely that those companies will take on a new customer.

Any words of advice or hope?